Predictive Assessment & Prevention

Experimental evidence is not a prerequisite for filing a patent application

ER Plumer

Molecular genetic factors as prognostic indicators in human renal cell carcinoma

R Erlandsson,P Collins & U Bergerheim

DNA content and thymidine-labeling index correlate with prognosis in squamous cell carcinoma of the larynx

Matturri L, Lavezzi AM, Biondo B, Ottaviani A

RT-PCR-monitoring of acute myeloid leukemia with T(15;17), T(8;21)and INV(16)

K Laczika, R Kusec, G Mitterbauer, M Mitterbauer, C Mannhalter, OA Haas, K Lechner, U Jager

The clinical trial for the prevention of hepatocarcinogenesis with beta-carotene

K Jinno, I Hyodo, M Tanimizu

Metabolism, uptake and excretion of a D-glucaric acid salt and its potential use in cancer prevention

Z Walaszek, J Szemraj, M Narog, AK Adams, U Sherman, M Hanausek

Cytotoxicity of NaCl, a stomach tumor promoter, and prevention by rice extract in stomach mucosa of F344 rats

C Furihata, H Ohta, T Tokuyama

Reactivative and antimutagenic effect of bacteria on chemically and UV-induced mutagenesis

L Vorobjeva, T Cherdinceva

Pharmacokinetic parameters as predictive factors of clinical response in anti-cancer chemotherapy

D Leveque, J Wihlm, F Jehl

Therapy by cytokines and activation of cellular immunity of cervical intraepithelial neoplasia(CIN) and cancer in situ(CIS)

K Ohkawa, M Ohkawa, R Ohkawa, T Ohkawa

Streptozotocin and nimustine combination therapy on recurrent human malignant gliomas

JM Chen, Y PeiZhang, KM Zhao, HZ Zuo

Therapy of malignant tumor of alveolus and prevention of recurrence by activation of cellular immunity against immuno-deficiency after chemotherapy or operation

M Ohkawa, K Ohkawa, R Ohkawa, T Ohkawa